Product image of Ipratropium Bromide/Salbutamol Neutec (Ipratropium Bromide, Salbutamol) supplied by GNH India

Ipratropium Bromide/Salbutamol Neutec

Active Ingredient:
Ipratropium Bromide, Salbutamol
Origin:
EU

Ipratropium Bromide/Salbutamol Neutec (Ipratropium Bromide, Salbutamol)

Ipratropium Bromide, the active ingredient in Ipratropium Bromide/Salbutamol Neutec, is a bronchodilator (Anticholinergic + Short‑acting β2‑agonist) presented as a combination inhalation product for inhalation use. It treats chronic obstructive pulmonary disease (COPD) and asthma in patients requiring rapid bronchodilation.

GNH India supplies Ipratropium Bromide/Salbutamol Neutec as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. It is manufactured to EU standards and distributed globally.

Manufacturer / TM Owner

Neutec Inhaler Ireland Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ipratropium Bromide/Salbutamol is a bronchodilator indicated for respiratory conditions that involve airway narrowing.

  • Chronic obstructive pulmonary disease (COPD): improves airflow and reduces breathlessness.
  • Asthma: provides rapid relief of bronchoconstriction and improves symptom control.
  • Bronchospasm: alleviates acute airway narrowing in various respiratory conditions.

How It Works

  • Ipratropium bromide competitively blocks muscarinic (M3) receptors on airway smooth muscle, preventing acetylcholine‑mediated bronchoconstriction. Salbutamol selectively stimulates β2‑adrenergic receptors, increasing intracellular cAMP and causing smooth‑muscle relaxation. The combined actions produce additive bronchodilation, enhancing airway patency in obstructive lung diseases.

Side Effects

The following adverse reactions have been reported with the combination inhalation product.

Common Side Effects

  • Dry mouth: reduced salivary secretion.
  • Cough or throat irritation: local irritation from inhaled particles.
  • Headache: mild to moderate intensity.
  • Tremor: fine muscle shaking, especially of the hands.
  • Palpitations: sensation of rapid or irregular heartbeat.
  • Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects

  • Paradoxical bronchospasm: worsening airway obstruction after inhalation.
  • Angioedema: swelling of the face, lips, or tongue.
  • Tachyarrhythmia: rapid or irregular heart rhythm.
  • Severe allergic reaction (anaphylaxis): systemic hypersensitivity.
  • Hyperglycaemia: elevated blood glucose, particularly in diabetic patients.

Precautions & Warnings

Before prescribing or using this inhalation product, consider the following precautions.

  • Assess renal function: ipratropium is renally excreted; dose adjustment may be needed in severe impairment.
  • Monitor cardiovascular status: salbutamol may cause tachycardia or palpitations.
  • Avoid use in patients with known hypersensitivity to either component.
  • Use with caution in patients with narrow‑angle glaucoma.
  • Do not exceed prescribed frequency: overuse increases risk of systemic side effects.
  • Store below 25°C: keep in original container, protect from moisture and heat.

Avoid Interactions

Potential drug interactions should be reviewed prior to initiating therapy.

Major Interactions (Avoid)

  • Beta‑blockers: may antagonize bronchodilator effect.
  • Monoamine oxidase inhibitors (MAOIs): risk of severe hypertension.
  • Tricyclic antidepressants: additive cardiovascular stimulation.
  • Diuretics: may exacerbate hypokalaemia.
  • Other anticholinergics: additive anticholinergic burden.

Moderate Interactions (Monitor Closely):\n- Theophylline: additive bronchodilation; monitor serum levels.

  • Corticosteroids: increased risk of oral thrush with inhaled use.
  • Diabetes medications: salbutamol can raise blood glucose levels.
  • Antihistamines: may increase dry‑mouth sensation.
  • Ritonavir: may increase salbutamol plasma concentrations.

Frequently Asked Questions

Ipratropium Bromide/Salbutamol Neutec is a prescription inhalation product that combines an anticholinergic and a short‑acting β2‑agonist. It is indicated for the relief of bronchoconstriction in chronic obstructive pulmonary disease (COPD) and asthma, providing rapid improvement in airflow and symptom control.

Ipratropium bromide blocks muscarinic (M3) receptors on airway smooth muscle, preventing acetylcholine from causing bronchoconstriction. By inhibiting this parasympathetic pathway, the airway caliber remains open, which helps reduce airflow limitation in obstructive lung diseases.

Salbutamol is a selective β2‑adrenergic receptor agonist. Stimulation of these receptors increases intracellular cyclic AMP, leading to relaxation of bronchial smooth muscle and bronchodilation. This rapid effect eases breathing difficulties during acute episodes.

The prescribed dose is determined by the treating clinician based on the patient’s condition, severity, and response. Typical regimens involve a specific number of inhalations per day, but exact dosing instructions must be obtained from a qualified healthcare professional.

Safety data for use during pregnancy and lactation are limited. The product should only be used if the potential benefit justifies any potential risk to the fetus or infant, and this decision must be made by the prescribing physician in consultation with the patient.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After verification of trade or institutional credentials, the sales team will provide pricing, availability, shipping details, and any required import documentation.

The combination offers additive bronchodilation by targeting two complementary pathways—muscarinic blockade and β2‑adrenergic stimulation—resulting in faster and more pronounced airway opening than either agent alone. This can improve symptom relief and reduce the need for higher individual doses.

Store the inhalation product below 25 °C in its original container, protecting it from moisture, heat, and direct sunlight. Keep the device clean according to the manufacturer’s instructions and avoid exposing it to freezing temperatures.

The product is delivered by inhalation, typically using a metered‑dose inhaler or nebulizer as directed by the prescriber. Patients should inhale the medication fully and hold their breath for a few seconds to maximize lung deposition.

Serious adverse events include paradoxical bronchospasm, angioedema, severe tachyarrhythmias, and anaphylactic reactions. If any of these occur, the patient should stop using the inhaler and seek immediate medical attention.

Patients with known hypersensitivity to ipratropium, salbutamol, or any excipients should avoid the product. It is also contraindicated in individuals with narrow‑angle glaucoma or those who have experienced a previous paradoxical bronchospasm after inhalation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ipratropium Bromide, Salbutamol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT